Skip to main content
Danielle Margalit, MD, Radiation Oncology, Boston, MA

DanielleN.MargalitMD

Radiation Oncology Boston, MA

Head & Neck

Associate Professor of Radiation Oncology, Harvard Medical School Staff Physician, Dana-Farber Cancer Institute and Brigham and Women's Hospital

Dr. Margalit is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Margalit's full profile

Already have an account?

  • Office

    450 Brookline Ave
    Boston, MA 02215
    Phone+1 617-632-3591

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2007 - 2011
  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2006 - 2010
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2007
  • Harvard Medical School
    Harvard Medical SchoolClass of 2006

Certifications & Licensure

  • ME State Medical License
    ME State Medical License 2020 - 2025
  • MA State Medical License
    MA State Medical License 2008 - 2024
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Trial “Informs Practice Tremendously” for Low-Risk HPV-Oropharyngeal Cancer
    Trial “Informs Practice Tremendously” for Low-Risk HPV-Oropharyngeal CancerOctober 8th, 2024
  • Standard Chemoradiation Remains Superior for HPV-Associated Oropharyngeal Cancer
    Standard Chemoradiation Remains Superior for HPV-Associated Oropharyngeal CancerOctober 4th, 2024
  • High Rates of Oropharynx Cancer Tied to HPV
    High Rates of Oropharynx Cancer Tied to HPVSeptember 11th, 2019
  • Join now to see all